Form 4 for IMUX IMMUNIC, INC.
Accepted 2021-08-11 00:00:00 ET · period of report 2021-08-10 · accession 0001193805-21-001161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-08-11 | 2021-08-10 | IMUX | Vitt Daniel | Pres, CEO, Dir | P - Purchase | $9.60 | +1,000 | 363.9K | +0.3% | +$9,600 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | P | A | 1,000 | $9.60 | 363,877 | I See footnote | — | — | (F1) 1,000 shares are owned directly by the Reporting Person and 362,877 shares are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares. |